NASDAQ | ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index.
The index includes exchange-listed companies, on a global basis, that derive a significant proportion of their revenues (or that have the potential to derive a significant proportion of their revenues) from the generic drug industry, or that have a primary business focus on the generic drug industry.
The fund normally invests at least 80% of its total assets in securities that comprise the fund&!39;s benchmark index.
It is non-diversified.
Top 15 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 9.65% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 9.36% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.81% |
| MYL | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.43% |
| ALB | Albemarle Corp | Basic Materials | Specialty Chemicals | 2.99% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.42% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.22% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.21% |
| PRAH | PRA Health Sciences Inc | Healthcare | Diagnostics & Research | 2.21% |
| RDY | Dr. Reddy’s Laboratories Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 2.12% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.85% |
| SYNH | Syneos Health Inc | Healthcare | Diagnostics & Research | 1.72% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 1.34% |
| ENDP | Endo International PLC | Healthcare | Pharmaceuticals | 0.59% |
| AMRX | Amneal Pharmaceuticals Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 0.52% |